Polar Asset Management Partners Inc.
Position in RNA — Atrium Therapeutics, Inc.
CIK 1326389
TORONTO, A6
Position in RNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,017,500
+$1,081,600 QoQ
Shares Held
150,000
+114.3% QoQ
Ownership
0.877%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#20
of 155 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Asset Management Partners Inc. holds $46,847,679 across 13 Biotechnology names. RNA ranks #2 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
322,467 | $42,801,044 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
This page
|
150,000 | $2,017,500 | |
| 3 | RANI |
Rani Therapeutics Holdings, Inc.
|
2,318,542 | $1,762,091 | |
| 4 | EXEL |
Exelixis, Inc.
|
4,908 | $267,044 | |
| 5 | 1,150,300 | $0 | |||
| 6 | 320,529 | $0 | |||
| 7 | 360,000 | $0 | |||
| 8 | ASBP |
Aspire Biopharma Holdings, Inc.
|
138,536 | $0 |
All Filings in RNA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,017,500 | 150,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $935,900 | 70,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||